US-based investment firm takes controlling stake in Opella, while France's government moves to ensure the company remains in ...

Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals ...

Vera Therapeutics appointed Amgen and Seagen alum Matt Skelton as EVP of commercial. Frank Lane was appointed SVP and head of ...

“The development of Muse, a result of our ongoing collaboration with OpenAI and Formation Bio, represents another proof point ...

Novavax's (NVAX) stock was trading down more than 6% Tuesday afternoon after the company lowered its guidance for sales for ...

Sanofi and Sudair Pharma Company (SPC) have joined forces to establish a state-of-the-art manufacturing facility within the Kingdom of Saudi Arabia, dedicated to the full production including delivery ...

In collaboration with AstraZeneca Plc AZN, which is responsible for manufacturing ... The company reaffirms that Dupixent will deliver around 13 billion euros in 2024 sales. Sanofi expects ...

Brad Lightcap, COO, OpenAI "We believe AI can accelerate drug development, bringing new treatments to patients more quickly. This first product from our collaboration with Sanofi and Formation Bio is ...

The deal values OranoMed at €1.9bn, as Sanofi becomes the latest big pharmaceutical company to explore one ... the group’s control of its entire manufacturing chain set it apart from rivals ...

NVAX reports encouraging third-quarter results. However, the stock falls due to management lowering its sales guidance, ...

Together, CD&R and Sanofi will support Opella’s growth strategy as a pure-play, global, and fast-moving consumer healthcare company ... in-class and strategic manufacturing sites and four ...